Collaborative usage/research locations

2016 Kanazawa University Cancer Research Institute Appeal for collaborative research tasks

 In Japan, a country with a rapidly aging society, cancer is the main cause of death, and one out of every three deaths is caused by cancer. Steady progress is being made with cancer treatment, but there are still many issues to overcome, such as drug resistance, etc., and society is making increasingly greater demands for cancer research. In order to deal with this social demand, Kanazawa University Cancer Research Institute has decided to play a central role in the field of “metastasis/drug resistance” research with the aim of promoting further development of research by widely adopting collaborative research with researchers from around Japan into the conditions of carcinogenesis/cancer metastasis/drug resistance, focusing on cancer stem cells/cancer microenvironments, as well as collaborative research relating to molecular targeted treatment. Kanazawa University Cancer Research Institute has been reauthorized by MEXT as a “leading collaborative research location for cancer metastasis/drug resistance” for six years starting from 2016, and in order to promote the operations of this location, an appeal is being made as follows for collaborative research to be carried out with teaching staff from this Institute, using the bio resources and state-of-the-art equipment available at this Institute.

No Item Domestic collaborative research International collaborative research
1 Qualified applicants Teaching staff/researchers belonging to universities and public research institutions
2 Research period April 1, 2016 to March 31, 2017
3 How to apply ① Refer to list of applicable research tasks and confirm details of collaborative research in advance with relevant teaching staff at this Institute. ② Produce written application
 Download application form here:
http://ganken.cri.kanazawa-u.ac.jp/cri/wpcontent/uploads/2016/01/H28_application_form.doc
③ Submit written application
 *Seal of agreement from Head of affiliated research institution must be imprinted on written application.
 *In the case of international collaborative research, a proxy application can be made by the relevant teaching staff at this Institute.
4 Deadline for submission of written application Must arrive by Friday 26 February, 2016 Any time
5 Address for submission of written application Kakumamachi, Kanazawa City, Ishikawa Prefecture 920-1192
 Official in charge of research collaboration
 Kanazawa University College of Medical, Pharmaceutical and Health Sciences Administration, Pharmacy and Cancer Research Support Division
 Tel: 076-264-6702
 Email: y-kenkyo@adm.kanazawa-u.ac.jp
6 Selection Examination by collaborative research specialist committee including extramural persons of learning and experience
7 Notification ① Applicants will be notified by Thursday 31 March, 2016
② Selected persons are commissioned as “Kanazawa University Cancer Research Institute collaborative research staff”
Any time
8 No. of projects selected Around 50
9 Necessary expenses Necessary expenses for collaborative research (consumable goods and travel expenses) are covered by the Institute within the allowed budget.
*Allowance for travel expenses is in accordance with Kanazawa University personnel travel expenses regulations
Travel expenses, hotel expenses and research funds when staying at the Institute for several days or longer to carry out collaborative research
10 Maximum budget 500,000 yen 300,000 yen
11 Submission of results report Thu. 28 April, 2017
① Designated form provided
② Method of completion, etc. communicated at later date
③ Reports will be published on the Institute website
12 Other requirements ① When results of the collaborative research are published as a thesis, a note of thanks must be stated and a separate printed copy must be submitted to the address given in section 5 “Address for submission of written application”. (This work is partly supported by “Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University.”)
② Intellectual property rights are handled by applying the Kanazawa University Collaborative Research Handling Regulations.
③ Participation in symposiums and results briefings organized by the location to the extent possible
13 Facilities and equipment available at this Institute (1) Collaborative research resources/collaborative usage facilities
  ① Human Cancer Tissue Bank
   a. Frozen tissue of respiratory cancer/digestive cancer
   b. Past cancer tissue samples at university hospital (approx. 2,000 cases)
  ② Mouse Carcinogenesis Model Tissue Bank
   a. Stomach cancer, brain tumor, leukemia
  ③ Human Cancer Cell Line Bank (more than 100 types of human cancer cell lines)
   Please refer to the website of this Institute for details of bank-related usage methods, etc.
   http://ganken.cri.kanazawa-u.ac.jp/cri/eng/co/human/
  ④ Medicine Library
   Please refer to the website of this Institute for details of Medicine Library types and usage methods, etc.
   http://ganken.cri.kanazawa-u.ac.jp/cri/eng/co/yakuzai/
  ⑤ Pre-clinical Research Facility (SPF mouse breeding facility with image diagnosis equipment installed (max. 500 cages))
  ⑥ Clinical Research Facility (ward facilities available for class I/II clinical trials)
(2) Central Research Resource Branch
Cell Sorter, Confocal Laser Microscope, Laser Microdissection
Microscopy System, Time Lapse Fluorescent Microscope Pathological Tissue Sample Support, etc.

List of applicable research tasks

No Name Applicable research task
Research field
1 Prof. Atsushi Hirao Clarification of stem cell characteristic control mechanism and investigation of cancer therapy target molecules
Division of Molecular Genetics
2 Prof. Masanobu Oshima Research into occurrence and malignancy mechanism of stomach
Division of Genetics
3 Prof. Chiaki Takahashi Investigation of metabolic foundation of undifferentiated cancer cells
Division of Oncology and Molecular Biology
4 Prof. Hiroshi Sato Functional analysis of MMP and related molecules in connection with cancer infiltration/metastasis
Division of Molecular Virology and Oncology
5 Prof. Naofumi Mukaida Clarification of cancer microenvironment adjustment mechanism due to chemokine/inflammatory cytokine
Division of Molecular Bioregulation
6 Prof. Takashi Suda Research of molecular mechanism of programmed cell death and roles in relation to cancer symptoms
Division of Immunology and Molecular Biology
7Prof. Kunio Matsumoto Cancer metastasis/drug resistance/tissue regeneration mechanism and drug discovery research centered on HGF-MET system
Division of Tumor Dynamics and Regulation
8 Prof. Noriko Gotoh Analysis of molecular mechanism of cancer malignancy using cancer stem cell culture system of solid cancer
Division of Cancer Cell Biology
9 Prof. Katsuji Yoshioka Research into cancer cell signaling
Division of Molecular Cell Signaling
10Prof. Toshinari Minamoto Diagnosis and R&D of treatment methods based on molecular pathogenesis and metabolic characteristics of digestive organs/intractable cancer
Division of Translational and Clinical Oncology
11 Prof. Takeshi Suzuki Research into epigenetic control of cancer malignancy
Division of Functional Genomics
12 Prof. Seiji Yano Development of new lung cancer treatments
Division of Medical Oncology

Other

Please refer to following page for details regarding the objectives, research tasks and latest results, etc. of each research division:
http://ganken.cri.kanazawa-u.ac.jp/cri/eng/about/